Highbridge Capital Management’s MedAssets MDAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-175,000
Closed -$5.42M – 2108
2015
Q4
$5.42M Sell
175,000
-28,802
-14% -$800K 0.08% 276
2015
Q3
$4.09M Sell
203,802
-329,992
-62% -$7.03M 0.06% 347
2015
Q2
$11.8M Sell
533,794
-303,019
-36% -$6.32M 0.15% 162
2015
Q1
$15.7M Sell
836,813
-469,394
-36% -$8.93M 0.22% 131
2014
Q4
$25.8M Buy
1,306,207
+613,492
+89% +$12.5M 0.33% 87
2014
Q3
$14.4M Sell
692,715
-427,234
-38% -$9.6M 0.19% 144
2014
Q2
$25.6M Buy
1,119,949
+1,096,344
+4,645% +$25.6M 0.31% 86
2014
Q1
$583K Sell
23,605
-356,574
-94% -$8.03M 0.01% 668
2013
Q4
$7.54M Buy
+380,179
New +$8.55M 0.09% 234
2013
Q3
– Sell
-22,277
Closed -$395K – 1657
2013
Q2
$395K Buy
+22,277
New +$400K ﹤0.01% 951

Highbridge Capital Management's MDAS Position: Q1 2016 in Review

Highbridge Capital Management sold out of MedAssets (MDAS) in Q1 2016, closing a stake of 175,000 shares — an estimated $5.42M sold.

Highbridge Capital Management first reported a position in MDAS in Q2 2013 and held it in 10 quarters. The position peaked at $25.8M in Q4 2014. 0 funds tracked by Wall St. Rank hold MDAS as of Q1 2016.

  • Highbridge Capital Management reported no remaining MedAssets position as of Q1 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 175,000 MedAssets shares in Q1 2016, an estimated $5.42M.
  • Highbridge Capital Management first reported a position in MedAssets in Q2 2013 and held it in 10 quarters.
  • Highbridge Capital Management's MedAssets position peaked at $25.8M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held MedAssets as of Q1 2016.

Based on Highbridge Capital Management's 13F filing for Q1 2016, filed 16 May 2016.